| 3.7 |
11.1 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 3.0 |
8.9 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 2.9 |
11.4 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 2.8 |
8.5 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 2.8 |
16.6 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 2.6 |
7.9 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 2.5 |
7.6 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 2.3 |
9.2 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 2.2 |
10.9 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 2.2 |
8.7 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 2.1 |
2.1 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 2.0 |
8.1 |
GO:1900451 |
positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 1.8 |
14.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 1.7 |
8.7 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 1.7 |
6.9 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 1.7 |
5.0 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 1.7 |
15.0 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 1.6 |
4.9 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 1.6 |
6.4 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 1.6 |
7.9 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 1.6 |
4.7 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 1.6 |
1.6 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 1.6 |
4.7 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 1.6 |
1.6 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 1.5 |
3.1 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 1.5 |
3.1 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 1.5 |
6.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 1.5 |
21.4 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 1.5 |
6.1 |
GO:0003360 |
brainstem development(GO:0003360) |
| 1.5 |
3.0 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 1.5 |
7.5 |
GO:0061110 |
dense core granule biogenesis(GO:0061110) |
| 1.5 |
4.5 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 1.4 |
7.1 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 1.4 |
12.7 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 1.4 |
8.4 |
GO:0035907 |
dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
| 1.4 |
4.2 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 1.4 |
4.2 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 1.4 |
4.1 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 1.4 |
8.1 |
GO:0060022 |
hard palate development(GO:0060022) |
| 1.3 |
2.7 |
GO:1900133 |
renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 1.3 |
19.4 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 1.3 |
1.3 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 1.3 |
10.0 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 1.2 |
1.2 |
GO:0071435 |
potassium ion export(GO:0071435) |
| 1.2 |
6.1 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 1.2 |
3.7 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 1.2 |
3.6 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 1.2 |
2.4 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) |
| 1.2 |
4.7 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 1.2 |
2.3 |
GO:0097491 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 1.2 |
4.6 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 1.1 |
3.4 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 1.1 |
4.6 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 1.1 |
3.4 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 1.1 |
3.4 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 1.1 |
4.4 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 1.1 |
4.3 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 1.1 |
3.2 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 1.1 |
2.1 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 1.0 |
7.3 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 1.0 |
8.1 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 1.0 |
3.0 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 1.0 |
1.0 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 1.0 |
3.0 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 1.0 |
1.0 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 1.0 |
1.0 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 1.0 |
9.9 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 1.0 |
8.7 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.9 |
2.8 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.9 |
2.8 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.9 |
6.6 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.9 |
0.9 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.9 |
0.9 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.9 |
1.8 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 0.9 |
11.8 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.9 |
5.4 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.9 |
0.9 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.9 |
0.9 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.9 |
2.6 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.9 |
11.4 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.9 |
0.9 |
GO:1901295 |
regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of heart induction(GO:1901321) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
| 0.9 |
0.9 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.9 |
5.2 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.9 |
5.2 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.9 |
3.4 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.9 |
2.6 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.9 |
0.9 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.8 |
2.5 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.8 |
1.7 |
GO:1902336 |
neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
| 0.8 |
0.8 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.8 |
2.5 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.8 |
4.2 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.8 |
2.5 |
GO:0071440 |
regulation of histone H3-K14 acetylation(GO:0071440) |
| 0.8 |
7.4 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.8 |
1.7 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.8 |
4.1 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.8 |
2.4 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.8 |
3.2 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.8 |
3.9 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.8 |
4.6 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.8 |
2.3 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 0.8 |
7.0 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.8 |
8.5 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.8 |
0.8 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.7 |
1.5 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.7 |
4.5 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.7 |
9.5 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.7 |
2.2 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.7 |
2.2 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.7 |
4.4 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.7 |
0.7 |
GO:0002718 |
regulation of cytokine production involved in immune response(GO:0002718) |
| 0.7 |
5.8 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.7 |
2.9 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.7 |
2.2 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.7 |
2.1 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.7 |
2.9 |
GO:0046476 |
glycosylceramide biosynthetic process(GO:0046476) |
| 0.7 |
2.1 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.7 |
5.0 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.7 |
3.5 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.7 |
6.3 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.7 |
0.7 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.7 |
2.0 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.7 |
3.4 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.7 |
0.7 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.7 |
4.0 |
GO:0031442 |
positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.7 |
1.3 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.7 |
4.7 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.7 |
3.3 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.7 |
2.7 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.7 |
2.6 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.7 |
3.3 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.7 |
2.0 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.7 |
3.9 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.7 |
0.7 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.6 |
1.9 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.6 |
1.9 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.6 |
1.9 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.6 |
0.6 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.6 |
1.3 |
GO:2000813 |
negative regulation of barbed-end actin filament capping(GO:2000813) |
| 0.6 |
1.9 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.6 |
1.9 |
GO:0051660 |
cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) |
| 0.6 |
9.5 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.6 |
3.2 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.6 |
1.9 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.6 |
3.1 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.6 |
4.4 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.6 |
3.1 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.6 |
1.9 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.6 |
3.1 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.6 |
5.6 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.6 |
3.7 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.6 |
2.5 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.6 |
2.5 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.6 |
1.2 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.6 |
1.8 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.6 |
1.8 |
GO:0010872 |
regulation of cholesterol esterification(GO:0010872) |
| 0.6 |
1.8 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.6 |
4.1 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.6 |
1.7 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.6 |
5.8 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.6 |
1.7 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.6 |
2.9 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.6 |
0.6 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.6 |
2.3 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.6 |
6.8 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.6 |
4.5 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.6 |
1.7 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.6 |
1.7 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.6 |
4.5 |
GO:0061038 |
uterus morphogenesis(GO:0061038) |
| 0.6 |
10.1 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.6 |
3.9 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.6 |
2.2 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.6 |
6.6 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.6 |
1.7 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.6 |
8.8 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.6 |
0.6 |
GO:0045472 |
response to ether(GO:0045472) |
| 0.5 |
3.3 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.5 |
6.5 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.5 |
4.8 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.5 |
1.1 |
GO:0061156 |
pulmonary artery morphogenesis(GO:0061156) |
| 0.5 |
2.7 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.5 |
2.7 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.5 |
1.1 |
GO:1903977 |
positive regulation of Schwann cell migration(GO:1900149) positive regulation of glial cell migration(GO:1903977) |
| 0.5 |
4.2 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.5 |
1.6 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.5 |
1.1 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.5 |
0.5 |
GO:0055024 |
regulation of cardiac muscle tissue development(GO:0055024) |
| 0.5 |
1.6 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.5 |
3.1 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.5 |
4.2 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.5 |
2.0 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.5 |
0.5 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.5 |
0.5 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.5 |
2.0 |
GO:0098908 |
regulation of neuronal action potential(GO:0098908) |
| 0.5 |
1.0 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 0.5 |
1.5 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.5 |
1.5 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.5 |
0.5 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.5 |
2.5 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.5 |
4.5 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.5 |
3.0 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.5 |
4.4 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.5 |
1.5 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.5 |
2.0 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.5 |
1.5 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.5 |
1.0 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.5 |
1.5 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.5 |
1.4 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.5 |
2.4 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.5 |
1.4 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.5 |
1.0 |
GO:0050859 |
B cell proliferation involved in immune response(GO:0002322) negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.5 |
3.4 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.5 |
1.9 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.5 |
0.5 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.5 |
5.2 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.5 |
0.9 |
GO:0045410 |
positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.5 |
10.0 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.5 |
1.9 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.5 |
2.4 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 0.5 |
1.9 |
GO:0071638 |
negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.5 |
4.2 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.5 |
1.9 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.5 |
4.2 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.5 |
1.4 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) |
| 0.5 |
1.4 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.5 |
2.3 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.4 |
5.8 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.4 |
0.9 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.4 |
1.8 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.4 |
6.7 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.4 |
1.3 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.4 |
2.2 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.4 |
1.3 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.4 |
1.3 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.4 |
0.9 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.4 |
0.9 |
GO:0061551 |
trigeminal ganglion development(GO:0061551) |
| 0.4 |
2.2 |
GO:0042518 |
negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
| 0.4 |
0.9 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 0.4 |
3.5 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.4 |
0.4 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 0.4 |
1.3 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.4 |
3.5 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.4 |
1.3 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.4 |
1.3 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.4 |
2.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.4 |
0.4 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
| 0.4 |
3.8 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.4 |
7.2 |
GO:0060384 |
innervation(GO:0060384) |
| 0.4 |
2.5 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.4 |
1.3 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.4 |
4.6 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.4 |
0.8 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.4 |
0.8 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.4 |
1.2 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.4 |
2.0 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.4 |
5.3 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.4 |
4.5 |
GO:0060746 |
parental behavior(GO:0060746) |
| 0.4 |
1.2 |
GO:2000834 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.4 |
3.6 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.4 |
6.0 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.4 |
1.6 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.4 |
2.4 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.4 |
2.4 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.4 |
1.6 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.4 |
8.7 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.4 |
2.0 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
| 0.4 |
0.8 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.4 |
1.5 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.4 |
2.3 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.4 |
3.1 |
GO:0034204 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.4 |
1.1 |
GO:0044827 |
modulation by host of viral genome replication(GO:0044827) |
| 0.4 |
0.8 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.4 |
0.4 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.4 |
2.7 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.4 |
2.6 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.4 |
1.9 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.4 |
1.1 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.4 |
1.5 |
GO:0072393 |
microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.4 |
1.1 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.4 |
1.1 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.4 |
1.9 |
GO:1904469 |
positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.4 |
1.9 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.4 |
1.5 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.4 |
1.1 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.4 |
1.8 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.4 |
0.7 |
GO:0097694 |
establishment of RNA localization to telomere(GO:0097694) |
| 0.4 |
4.0 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.4 |
0.7 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.4 |
2.2 |
GO:0039535 |
regulation of RIG-I signaling pathway(GO:0039535) |
| 0.4 |
2.9 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.4 |
2.5 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.4 |
0.4 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.4 |
1.1 |
GO:0044337 |
canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
| 0.4 |
1.1 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.4 |
1.8 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.4 |
1.1 |
GO:0010814 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.4 |
1.1 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.4 |
0.7 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.4 |
3.9 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.3 |
3.5 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.3 |
3.8 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.3 |
1.7 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.3 |
2.1 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.3 |
0.7 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.3 |
1.7 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.3 |
3.1 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.3 |
2.0 |
GO:0018377 |
N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.3 |
0.7 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.3 |
1.7 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.3 |
1.0 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.3 |
0.3 |
GO:0043497 |
regulation of protein heterodimerization activity(GO:0043497) |
| 0.3 |
0.7 |
GO:0086068 |
Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.3 |
2.9 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.3 |
1.6 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.3 |
0.9 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.3 |
0.3 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.3 |
5.7 |
GO:0006978 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
| 0.3 |
1.3 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.3 |
0.3 |
GO:0031052 |
programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
| 0.3 |
7.4 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.3 |
2.5 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.3 |
0.9 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.3 |
0.6 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 0.3 |
1.8 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.3 |
0.6 |
GO:0051450 |
myoblast proliferation(GO:0051450) |
| 0.3 |
0.3 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.3 |
0.9 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.3 |
9.3 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.3 |
0.9 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.3 |
1.2 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.3 |
0.3 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.3 |
2.4 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.3 |
0.3 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
| 0.3 |
8.2 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.3 |
0.6 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.3 |
1.5 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.3 |
3.5 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.3 |
1.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 |
1.1 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.3 |
1.4 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.3 |
1.1 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.3 |
6.2 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.3 |
1.4 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.3 |
0.8 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.3 |
1.4 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.3 |
0.8 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.3 |
2.2 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.3 |
0.3 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.3 |
1.1 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.3 |
2.2 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.3 |
1.1 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.3 |
5.2 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.3 |
0.8 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.3 |
0.3 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.3 |
2.2 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.3 |
1.6 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.3 |
0.5 |
GO:0090160 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) Golgi to lysosome transport(GO:0090160) |
| 0.3 |
1.3 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.3 |
2.4 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.3 |
4.8 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.3 |
1.1 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
| 0.3 |
1.1 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.3 |
2.4 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 0.3 |
0.8 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.3 |
0.8 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.3 |
2.1 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.3 |
1.1 |
GO:0003263 |
cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
| 0.3 |
0.5 |
GO:0071455 |
cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
| 0.3 |
1.8 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.3 |
5.2 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.3 |
2.1 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.3 |
0.3 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.3 |
0.8 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.3 |
0.8 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.3 |
1.3 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.3 |
0.5 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.3 |
2.6 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.3 |
1.6 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.3 |
3.1 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.3 |
1.8 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.3 |
0.5 |
GO:0072074 |
kidney mesenchyme development(GO:0072074) |
| 0.3 |
2.3 |
GO:0032875 |
regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.3 |
0.5 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.2 |
2.0 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.2 |
1.5 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.2 |
3.5 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.2 |
0.7 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.2 |
0.5 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
| 0.2 |
1.7 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 |
1.0 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.2 |
0.2 |
GO:0060129 |
thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.2 |
0.7 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 |
0.7 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.2 |
0.7 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.2 |
3.9 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 |
2.7 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.2 |
1.9 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.2 |
1.7 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.2 |
0.7 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.2 |
0.7 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.2 |
1.2 |
GO:0033574 |
response to testosterone(GO:0033574) |
| 0.2 |
0.5 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.2 |
1.9 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.2 |
0.7 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.2 |
0.9 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.2 |
0.7 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.2 |
5.2 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.2 |
0.5 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.2 |
0.2 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.2 |
0.7 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.2 |
0.5 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 |
0.9 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.2 |
1.4 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.2 |
0.7 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.2 |
2.6 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.2 |
1.4 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.2 |
2.1 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.2 |
1.6 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.2 |
0.9 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 0.2 |
3.0 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.2 |
0.7 |
GO:1903748 |
negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.2 |
2.5 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.2 |
0.5 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) |
| 0.2 |
0.5 |
GO:2000224 |
testosterone biosynthetic process(GO:0061370) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.2 |
0.9 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.2 |
1.1 |
GO:0070670 |
response to interleukin-4(GO:0070670) |
| 0.2 |
0.7 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.2 |
0.4 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.2 |
1.1 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.2 |
2.9 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
1.8 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
0.9 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.2 |
0.9 |
GO:0003340 |
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
| 0.2 |
3.0 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.2 |
0.6 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.2 |
0.2 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 |
0.2 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.2 |
2.8 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.2 |
0.2 |
GO:0010612 |
regulation of cardiac muscle adaptation(GO:0010612) |
| 0.2 |
0.2 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.2 |
2.6 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.2 |
2.1 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.2 |
1.7 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.2 |
1.1 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.2 |
0.6 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.2 |
0.4 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.2 |
0.2 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.2 |
1.9 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.2 |
1.5 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
| 0.2 |
5.0 |
GO:0034243 |
regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.2 |
0.8 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.2 |
1.0 |
GO:0060295 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.2 |
0.8 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.2 |
0.8 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.2 |
0.6 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.2 |
0.6 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.2 |
0.4 |
GO:0048636 |
positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
| 0.2 |
0.6 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.2 |
1.6 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.2 |
0.4 |
GO:0043267 |
negative regulation of potassium ion transport(GO:0043267) |
| 0.2 |
1.2 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
| 0.2 |
0.2 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 |
0.2 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.2 |
1.2 |
GO:0035437 |
maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.2 |
1.0 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 |
1.8 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 |
2.2 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.2 |
0.8 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.2 |
0.4 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 |
0.2 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 |
1.0 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.2 |
0.2 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.2 |
5.4 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.2 |
0.8 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.2 |
0.4 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 |
0.4 |
GO:1900424 |
regulation of defense response to bacterium(GO:1900424) |
| 0.2 |
5.8 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.2 |
0.4 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.2 |
1.1 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.2 |
0.2 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.2 |
0.6 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.2 |
4.6 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.2 |
0.6 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.2 |
1.7 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 |
0.6 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 |
7.5 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.2 |
0.9 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) |
| 0.2 |
0.4 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.2 |
1.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.2 |
1.7 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.2 |
0.6 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.2 |
0.2 |
GO:2000508 |
negative regulation of interleukin-1 secretion(GO:0050711) regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.2 |
0.2 |
GO:0021756 |
striatum development(GO:0021756) |
| 0.2 |
1.5 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.2 |
0.5 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 0.2 |
0.9 |
GO:1903236 |
regulation of leukocyte tethering or rolling(GO:1903236) |
| 0.2 |
0.5 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.2 |
0.9 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.2 |
2.9 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.2 |
0.5 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.2 |
1.5 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.2 |
0.5 |
GO:2000288 |
positive regulation of myoblast proliferation(GO:2000288) |
| 0.2 |
1.1 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.2 |
1.4 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.2 |
1.3 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.2 |
1.3 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.2 |
0.7 |
GO:1904667 |
negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.2 |
0.7 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 0.2 |
1.2 |
GO:0097369 |
sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.2 |
1.4 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.2 |
1.2 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.2 |
0.4 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.2 |
0.7 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.2 |
0.5 |
GO:1900107 |
regulation of nodal signaling pathway(GO:1900107) |
| 0.2 |
0.4 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.2 |
1.9 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 |
0.3 |
GO:1900044 |
regulation of protein K63-linked ubiquitination(GO:1900044) |
| 0.2 |
0.7 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 |
0.9 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.2 |
1.0 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.2 |
2.8 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.2 |
0.5 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.2 |
0.5 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 |
0.5 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.2 |
0.5 |
GO:0007063 |
regulation of sister chromatid cohesion(GO:0007063) |
| 0.2 |
2.0 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.2 |
4.9 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.2 |
3.2 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.2 |
0.5 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.2 |
1.3 |
GO:0072584 |
caveolin-mediated endocytosis(GO:0072584) |
| 0.2 |
0.3 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 |
0.7 |
GO:0086016 |
AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
| 0.2 |
0.5 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.2 |
1.7 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.2 |
1.7 |
GO:0034377 |
plasma lipoprotein particle assembly(GO:0034377) |
| 0.2 |
0.2 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) |
| 0.2 |
0.2 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.2 |
1.3 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.2 |
2.0 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
3.6 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.2 |
1.6 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.2 |
0.5 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.2 |
0.3 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 |
0.7 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.2 |
0.2 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.2 |
0.7 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.2 |
3.3 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.2 |
0.3 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.2 |
0.7 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.2 |
0.3 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.2 |
1.0 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.2 |
2.1 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.2 |
0.5 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.2 |
1.5 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.2 |
2.9 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.2 |
0.5 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 0.2 |
0.3 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.2 |
0.8 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.2 |
1.1 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.2 |
1.8 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.2 |
4.7 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.2 |
0.5 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.2 |
4.3 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.2 |
0.6 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 |
0.3 |
GO:0045006 |
DNA deamination(GO:0045006) |
| 0.2 |
0.2 |
GO:0035993 |
deltoid tuberosity development(GO:0035993) |
| 0.2 |
1.4 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.2 |
1.1 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) |
| 0.2 |
1.4 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.2 |
2.0 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.2 |
0.6 |
GO:0090188 |
negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.2 |
0.5 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.2 |
0.5 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.2 |
1.2 |
GO:0014904 |
myotube cell development(GO:0014904) |
| 0.2 |
1.1 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 |
0.3 |
GO:0043369 |
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
| 0.2 |
0.8 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 |
0.9 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.2 |
0.8 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.2 |
0.9 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
1.1 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.2 |
0.8 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.2 |
2.3 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.2 |
0.2 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.2 |
0.2 |
GO:0051769 |
nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
| 0.2 |
0.3 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.2 |
2.3 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.2 |
1.5 |
GO:0008105 |
asymmetric protein localization(GO:0008105) |
| 0.2 |
0.8 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.2 |
0.2 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.1 |
0.4 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
0.7 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.9 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
0.3 |
GO:0003413 |
chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.1 |
0.1 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.1 |
19.9 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 |
0.1 |
GO:2000773 |
negative regulation of cellular senescence(GO:2000773) |
| 0.1 |
2.5 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 |
0.1 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.9 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
0.1 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.1 |
0.4 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
0.6 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.1 |
0.1 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.1 |
0.4 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.1 |
0.7 |
GO:0097194 |
execution phase of apoptosis(GO:0097194) |
| 0.1 |
3.1 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.1 |
1.6 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.4 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
0.4 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
0.4 |
GO:1902895 |
positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.1 |
1.3 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.1 |
0.7 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.1 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.1 |
0.1 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.1 |
2.6 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
3.3 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.1 |
1.1 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 |
0.5 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.1 |
0.5 |
GO:0021871 |
forebrain regionalization(GO:0021871) |
| 0.1 |
0.9 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
1.1 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.1 |
1.3 |
GO:0036093 |
germ cell proliferation(GO:0036093) |
| 0.1 |
0.1 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 |
2.8 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
0.9 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.1 |
0.4 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.1 |
0.4 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 |
1.6 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.1 |
2.4 |
GO:0098927 |
early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.1 |
0.1 |
GO:0002444 |
myeloid leukocyte mediated immunity(GO:0002444) |
| 0.1 |
0.1 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.1 |
0.9 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
1.2 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.1 |
1.2 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.1 |
1.0 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.3 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.1 |
0.5 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.4 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 |
0.4 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 |
0.6 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 |
1.5 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.1 |
0.1 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.1 |
3.2 |
GO:1902850 |
mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.1 |
0.6 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.1 |
0.1 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.1 |
0.5 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
2.0 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.2 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.1 |
0.2 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 |
0.4 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 |
1.3 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 |
0.4 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 |
0.2 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.1 |
0.7 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 |
0.4 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 |
0.5 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 |
0.9 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
6.2 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.5 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
0.2 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.1 |
0.8 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.1 |
0.3 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.1 |
0.8 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.1 |
0.1 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.1 |
0.2 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 |
1.0 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.1 |
0.5 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.1 |
0.3 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.8 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 |
0.9 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.1 |
3.3 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.1 |
0.6 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.1 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) oxidative demethylation(GO:0070989) |
| 0.1 |
0.3 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.1 |
GO:0003161 |
cardiac conduction system development(GO:0003161) |
| 0.1 |
0.1 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.1 |
0.8 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.1 |
0.6 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
0.3 |
GO:1990000 |
amyloid fibril formation(GO:1990000) |
| 0.1 |
0.2 |
GO:2000020 |
positive regulation of male gonad development(GO:2000020) |
| 0.1 |
1.0 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
0.8 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.1 |
0.7 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
0.1 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.1 |
0.4 |
GO:0003254 |
regulation of membrane depolarization(GO:0003254) |
| 0.1 |
0.4 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.1 |
0.2 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.1 |
0.2 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.1 |
0.4 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.1 |
2.1 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.1 |
3.5 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.1 |
0.6 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 |
0.7 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
1.7 |
GO:0030219 |
megakaryocyte differentiation(GO:0030219) |
| 0.1 |
2.3 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.1 |
0.2 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.1 |
1.0 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.1 |
0.4 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 |
0.8 |
GO:0051383 |
kinetochore organization(GO:0051383) |
| 0.1 |
0.5 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.1 |
0.1 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.1 |
0.1 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.1 |
0.6 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.1 |
0.2 |
GO:1903333 |
regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
| 0.1 |
0.6 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
1.1 |
GO:0050820 |
positive regulation of coagulation(GO:0050820) |
| 0.1 |
0.1 |
GO:0032930 |
positive regulation of superoxide anion generation(GO:0032930) |
| 0.1 |
3.3 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) |
| 0.1 |
0.1 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.1 |
1.1 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.1 |
0.1 |
GO:1903335 |
regulation of vacuolar transport(GO:1903335) |
| 0.1 |
0.4 |
GO:0019348 |
polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
| 0.1 |
0.3 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
0.4 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
0.3 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
1.8 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
0.6 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 |
1.0 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
1.9 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.1 |
1.0 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.1 |
0.3 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
1.4 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.1 |
0.6 |
GO:0061245 |
establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
| 0.1 |
1.0 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.1 |
0.1 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.1 |
0.5 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
1.0 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.1 |
0.2 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.1 |
0.4 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 |
0.8 |
GO:1903078 |
positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.1 |
0.5 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
0.1 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.1 |
0.8 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.5 |
GO:0031124 |
mRNA 3'-end processing(GO:0031124) |
| 0.1 |
0.3 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
2.0 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.1 |
0.1 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
5.1 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.1 |
0.4 |
GO:0072344 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) rescue of stalled ribosome(GO:0072344) |
| 0.1 |
1.0 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
0.2 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.1 |
0.1 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.1 |
0.2 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.1 |
0.5 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.1 |
0.4 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.1 |
0.4 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.2 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.1 |
0.1 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.1 |
7.0 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.1 |
0.1 |
GO:1903312 |
negative regulation of mRNA metabolic process(GO:1903312) |
| 0.1 |
0.4 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.1 |
0.5 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
0.2 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
0.7 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.3 |
GO:1902224 |
ketone body metabolic process(GO:1902224) |
| 0.1 |
3.5 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.1 |
0.4 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 |
0.3 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 |
0.9 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
0.5 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
0.6 |
GO:0035510 |
DNA dealkylation(GO:0035510) |
| 0.1 |
2.5 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 |
0.4 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 |
1.3 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.1 |
0.2 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) flavin-containing compound metabolic process(GO:0042726) |
| 0.1 |
0.2 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.1 |
1.4 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.1 |
1.8 |
GO:0050879 |
multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.1 |
0.2 |
GO:0051642 |
centrosome localization(GO:0051642) |
| 0.1 |
0.2 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.3 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.1 |
0.2 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.1 |
1.9 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.9 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
0.2 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.1 |
1.5 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.1 |
0.4 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.1 |
0.2 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.1 |
0.6 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
0.2 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.2 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.1 |
0.3 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.1 |
1.6 |
GO:0001841 |
neural tube formation(GO:0001841) |
| 0.1 |
0.5 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.1 |
1.4 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.6 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.2 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.1 |
0.4 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.1 |
0.5 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
0.3 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 |
1.2 |
GO:0033048 |
negative regulation of mitotic sister chromatid segregation(GO:0033048) |
| 0.1 |
0.2 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.1 |
0.3 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.1 |
0.1 |
GO:0032303 |
regulation of icosanoid secretion(GO:0032303) |
| 0.1 |
0.8 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 |
3.5 |
GO:0035308 |
negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
| 0.1 |
0.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
0.2 |
GO:0048302 |
regulation of isotype switching to IgG isotypes(GO:0048302) positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 |
0.1 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.1 |
0.1 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.1 |
0.3 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 |
0.1 |
GO:0071514 |
genetic imprinting(GO:0071514) |
| 0.1 |
0.6 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.1 |
0.3 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.1 |
0.3 |
GO:0045908 |
negative regulation of vasodilation(GO:0045908) |
| 0.1 |
0.4 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.1 |
0.3 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.7 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.1 |
0.3 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.1 |
0.1 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.5 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
0.3 |
GO:0035561 |
regulation of chromatin binding(GO:0035561) |
| 0.1 |
0.4 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 |
0.1 |
GO:0043368 |
positive T cell selection(GO:0043368) |
| 0.1 |
0.1 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
| 0.1 |
0.2 |
GO:0051657 |
maintenance of organelle location(GO:0051657) |
| 0.1 |
0.2 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.1 |
2.9 |
GO:0032204 |
regulation of telomere maintenance(GO:0032204) |
| 0.1 |
0.2 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
0.3 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.1 |
0.3 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 |
0.1 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.1 |
0.6 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
| 0.1 |
0.1 |
GO:1904872 |
RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 0.1 |
0.4 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.1 |
0.6 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
0.1 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 0.1 |
0.7 |
GO:0060122 |
inner ear receptor stereocilium organization(GO:0060122) |
| 0.1 |
0.3 |
GO:0060900 |
embryonic camera-type eye formation(GO:0060900) |
| 0.1 |
0.2 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.1 |
0.4 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.5 |
GO:0046928 |
regulation of neurotransmitter secretion(GO:0046928) |
| 0.1 |
0.2 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
0.1 |
GO:2001180 |
negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.1 |
0.4 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.2 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
0.7 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 |
0.1 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.1 |
0.2 |
GO:1903887 |
motile primary cilium assembly(GO:1903887) |
| 0.1 |
0.3 |
GO:0045724 |
positive regulation of cilium assembly(GO:0045724) |
| 0.1 |
0.1 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
0.1 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.1 |
0.8 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 |
0.1 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.1 |
0.1 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 |
0.3 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.1 |
0.3 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.1 |
0.1 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.6 |
GO:0043470 |
regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
| 0.1 |
1.1 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.1 |
0.4 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.1 |
0.1 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 |
0.2 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.1 |
0.5 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.2 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.1 |
0.3 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.3 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 |
0.1 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.1 |
0.2 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.1 |
1.1 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
0.3 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.1 |
0.7 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 |
0.1 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.1 |
0.1 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.1 |
0.7 |
GO:0051489 |
regulation of filopodium assembly(GO:0051489) |
| 0.1 |
0.2 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 |
0.2 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.1 |
0.2 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.1 |
0.1 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 |
0.2 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.1 |
0.6 |
GO:0031397 |
negative regulation of protein ubiquitination(GO:0031397) |
| 0.1 |
0.2 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.1 |
0.3 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
0.1 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
0.3 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.1 |
0.5 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.1 |
0.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.0 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.0 |
0.1 |
GO:1904683 |
regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.0 |
0.8 |
GO:0051647 |
nucleus localization(GO:0051647) |
| 0.0 |
0.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.1 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.0 |
0.6 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.7 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.0 |
0.2 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.0 |
0.1 |
GO:0019659 |
fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.0 |
0.3 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.2 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.2 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 |
0.4 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.0 |
0.1 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.0 |
0.3 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.0 |
0.3 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.0 |
0.1 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.0 |
0.9 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.0 |
0.5 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.0 |
0.8 |
GO:0097576 |
autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
| 0.0 |
0.6 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.0 |
0.3 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.0 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.0 |
0.5 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.0 |
0.2 |
GO:0035066 |
positive regulation of histone acetylation(GO:0035066) |
| 0.0 |
0.7 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 |
0.2 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 |
0.2 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.0 |
0.2 |
GO:0000479 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.0 |
0.1 |
GO:0072578 |
neurotransmitter-gated ion channel clustering(GO:0072578) |
| 0.0 |
0.1 |
GO:0000966 |
RNA 5'-end processing(GO:0000966) |
| 0.0 |
0.3 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.0 |
0.2 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.4 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 |
0.2 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.0 |
0.1 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.0 |
0.4 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.0 |
0.1 |
GO:0051567 |
histone H3-K9 methylation(GO:0051567) |
| 0.0 |
0.3 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.0 |
0.0 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.0 |
0.6 |
GO:0002224 |
toll-like receptor signaling pathway(GO:0002224) |
| 0.0 |
0.1 |
GO:0046655 |
folic acid metabolic process(GO:0046655) |
| 0.0 |
0.5 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.0 |
0.0 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.0 |
0.2 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.0 |
0.2 |
GO:0050850 |
positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.0 |
0.2 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.0 |
0.2 |
GO:0042755 |
eating behavior(GO:0042755) |
| 0.0 |
1.3 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.0 |
0.3 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.1 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.0 |
0.2 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.0 |
0.1 |
GO:0097341 |
inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.0 |
0.3 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 0.0 |
0.3 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.1 |
GO:0098534 |
centriole replication(GO:0007099) centriole assembly(GO:0098534) |
| 0.0 |
0.3 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.1 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.0 |
0.0 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.0 |
0.2 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.0 |
0.1 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.0 |
0.6 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
0.0 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.0 |
0.3 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.0 |
0.4 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 |
0.3 |
GO:0043687 |
post-translational protein modification(GO:0043687) |
| 0.0 |
0.1 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.1 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.0 |
6.9 |
GO:0006397 |
mRNA processing(GO:0006397) |
| 0.0 |
0.2 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.0 |
0.3 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.0 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.0 |
0.2 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 |
0.1 |
GO:0046543 |
development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 0.0 |
5.1 |
GO:0006281 |
DNA repair(GO:0006281) |
| 0.0 |
0.1 |
GO:0035358 |
regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.0 |
0.5 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.1 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.0 |
0.1 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.0 |
0.1 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.0 |
0.3 |
GO:0090022 |
regulation of neutrophil chemotaxis(GO:0090022) |
| 0.0 |
0.1 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.0 |
0.3 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.0 |
0.1 |
GO:0098751 |
bone cell development(GO:0098751) |
| 0.0 |
0.2 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.0 |
0.1 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.0 |
0.7 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.1 |
GO:0071472 |
cellular response to salt stress(GO:0071472) |
| 0.0 |
0.1 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.0 |
0.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.0 |
GO:0009620 |
response to fungus(GO:0009620) |
| 0.0 |
0.1 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 |
0.1 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.0 |
0.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.3 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
0.0 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 |
0.1 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.0 |
0.0 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.1 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.0 |
0.1 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.0 |
0.0 |
GO:0010886 |
cholesterol storage(GO:0010878) regulation of cholesterol storage(GO:0010885) positive regulation of cholesterol storage(GO:0010886) |
| 0.0 |
0.0 |
GO:0043558 |
regulation of translational initiation in response to stress(GO:0043558) |
| 0.0 |
0.3 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.1 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.0 |
0.1 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.0 |
0.3 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.0 |
0.1 |
GO:0045620 |
negative regulation of lymphocyte differentiation(GO:0045620) |
| 0.0 |
0.3 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.0 |
0.0 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.0 |
0.1 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.0 |
0.0 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.0 |
0.0 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.0 |
0.4 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.0 |
0.5 |
GO:0034249 |
negative regulation of cellular amide metabolic process(GO:0034249) |
| 0.0 |
0.0 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.0 |
0.1 |
GO:0045954 |
positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.0 |
0.1 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
0.0 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.0 |
0.0 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.0 |
0.1 |
GO:0006544 |
glycine metabolic process(GO:0006544) |
| 0.0 |
0.1 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.0 |
0.2 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.0 |
0.1 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.0 |
0.6 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.0 |
0.1 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.0 |
0.2 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.0 |
0.0 |
GO:0072501 |
cellular divalent inorganic anion homeostasis(GO:0072501) |
| 0.0 |
0.1 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.1 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 |
1.5 |
GO:0060271 |
cilium morphogenesis(GO:0060271) |
| 0.0 |
0.1 |
GO:0015744 |
succinate transport(GO:0015744) |
| 0.0 |
0.0 |
GO:0060677 |
ureteric bud elongation(GO:0060677) ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.0 |
0.1 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.0 |
0.1 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.0 |
0.8 |
GO:0032886 |
regulation of microtubule-based process(GO:0032886) |
| 0.0 |
0.0 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.0 |
0.1 |
GO:2000489 |
hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 |
0.1 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 |
0.0 |
GO:0043030 |
regulation of macrophage activation(GO:0043030) |
| 0.0 |
0.1 |
GO:0014742 |
positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.0 |
0.1 |
GO:0098868 |
endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
| 0.0 |
0.0 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.0 |
0.6 |
GO:0000086 |
G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.0 |
0.1 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.0 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.0 |
0.0 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.0 |
0.0 |
GO:0009048 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 |
0.0 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.0 |
0.2 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
0.0 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 |
0.0 |
GO:0051791 |
medium-chain fatty acid metabolic process(GO:0051791) |
| 0.0 |
0.0 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 |
0.1 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.0 |
0.0 |
GO:0097484 |
dendrite extension(GO:0097484) |
